Literature DB >> 33980630

Pharmacotherapy management of schizophrenia for family physicians.

Japheth Bool1, Alex Crawley2, Annabelle Wanson3, Breanna Davis4, Katelyn Halpape5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33980630      PMCID： PMC8115962          DOI： 10.46747/cfp.6705350

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  19 in total

1.  20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia.

Authors:  Jari Tiihonen; Antti Tanskanen; Heidi Taipale
Journal:  Am J Psychiatry       Date:  2018-04-06       Impact factor: 18.112

2.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

Review 3.  Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders.

Authors:  David Crockford; Donald Addington
Journal:  Can J Psychiatry       Date:  2017-09       Impact factor: 4.356

Review 4.  What Is the Place of Clozapine in the Treatment of Early Psychosis in Canada?

Authors:  Richard Williams; Ashok Malla; Marc-Andre Roy; Ridha Joober; Rahul Manchanda; Phil Tibbo; Nicola Banks; Ofer Agid
Journal:  Can J Psychiatry       Date:  2016-07-09       Impact factor: 4.356

Review 5.  Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis.

Authors:  Jian-Ping Zhang; Juan A Gallego; Delbert G Robinson; Anil K Malhotra; John M Kane; Christoph U Correll
Journal:  Int J Neuropsychopharmacol       Date:  2012-12-03       Impact factor: 5.176

6.  Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial.

Authors:  John M Kane; Nina R Schooler; Patricia Marcy; Christoph U Correll; Eric D Achtyes; Robert D Gibbons; Delbert G Robinson
Journal:  JAMA Psychiatry       Date:  2020-12-01       Impact factor: 21.596

Review 7.  Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: a protocol for a systematic review.

Authors:  Agumasie Semahegn; Kwasi Torpey; Abubakar Manu; Nega Assefa; Gezahegn Tesfaye; Augustine Ankomah
Journal:  Syst Rev       Date:  2018-01-22

8.  Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.

Authors:  Maximilian Huhn; Adriani Nikolakopoulou; Johannes Schneider-Thoma; Marc Krause; Myrto Samara; Natalie Peter; Thomas Arndt; Lio Bäckers; Philipp Rothe; Andrea Cipriani; John Davis; Georgia Salanti; Stefan Leucht
Journal:  Lancet       Date:  2019-07-11       Impact factor: 79.321

9.  Management of antipsychotic-induced hyperprolactinemia.

Authors:  Ashley Tewksbury; Amy Olander
Journal:  Ment Health Clin       Date:  2016-06-29
View more
  2 in total

1.  Characterising methamphetamine use to inform health and social policies in Manitoba, Canada: a protocol for a retrospective cohort study using linked administrative data.

Authors:  Nathan C Nickel; Jennifer E Enns; Amy Freier; Scott C McCulloch; Mariette Chartier; Hera J M Casidsid; Oludolapo Deborah Balogun; Drew Mulhall; Roxana Dragan; Joykrishna Sarkar; James Bolton; Geoffrey Konrad; Wanda Phillips-Beck; Julianne Sanguins; Carolyn Shimmin; Neil McDonald; Javier Mignone; Aynslie Hinds
Journal:  BMJ Open       Date:  2022-10-19       Impact factor: 3.006

2.  Cognitive dysfunction and disability in people living with schizophrenia.

Authors:  B Srisudha; Dheeraj Kattula; Shanmugasundaram Devika; Arun Rachana
Journal:  J Family Med Prim Care       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.